| Facile synthesis of 1, 3-thiazolidin-4-ones as antitubercular agents DD Subhedar, MH Shaikh, MA Arkile, A Yeware, D Sarkar, BB Shingate Bioorganic & Medicinal Chemistry Letters 26 (7), 1704-1708, 2016 | 69 | 2016 |
| Novel tetrazoloquinoline–rhodanine conjugates: highly efficient synthesis and biological evaluation DD Subhedar, MH Shaikh, L Nawale, A Yeware, D Sarkar, FAK Khan, ... Bioorganic & Medicinal Chemistry Letters 26 (9), 2278-2283, 2016 | 54 | 2016 |
| Synthesis and docking studies of pyrazine–thiazolidinone hybrid scaffold targeting dormant tuberculosis TS Chitre, KD Asgaonkar, PB Miniyar, AB Dharme, MA Arkile, A Yeware, ... Bioorganic & Medicinal Chemistry Letters 26 (9), 2224-2228, 2016 | 31 | 2016 |
| [Et3NH][HSO4] catalyzed efficient synthesis of 5-arylidene-rhodanine conjugates and their antitubercular activity DD Subhedar, MH Shaikh, L Nawale, A Yeware, D Sarkar, BB Shingate Research on chemical Intermediates 42, 6607-6626, 2016 | 30 | 2016 |
| GSH induced controlled release of levofloxacin from a purpose-built prodrug: luminescence response for probing the drug release in Escherichia coli and Staphylococcus aureus S Pal, V Ramu, N Taye, DG Mogare, AM Yeware, D Sarkar, DS Reddy, ... Bioconjugate Chemistry 27 (9), 2062-2070, 2016 | 23 | 2016 |
| Superoxide generation and its involvement in the growth of Mycobacterium smegmatis AM Yeware, KD Shurpali, MC Athalye, D Sarkar Frontiers in Microbiology 8, 229605, 2017 | 18 | 2017 |
| Novel red fluorescence protein based microplate assay for drug screening against dormant Mycobacterium tuberculosis by using paraffin A Yeware, D Sarkar Tuberculosis 110, 15-19, 2018 | 13 | 2018 |
| Aptamer functionalized multifunctional fluorescent nanotheranostic platform for pancreatic cancer P Nigam, S Waghmode, A Yeware, L Nawale, P Dagde, A Dhudhane, ... Journal of Nanopharmaceutics and Drug Delivery 2 (4), 280-287, 2014 | 11 | 2014 |
| Using diphenyleneiodonium to induce a viable but non-culturable phenotype in Mycobacterium tuberculosis and its metabolomics analysis A Yeware, S Gample, S Agrawal, D Sarkar PloS one 14 (8), e0220628, 2019 | 10 | 2019 |
| Antibacterial and anti-TB tat-peptidomimetics with improved efficacy and half-life GS Bhosle, L Nawale, AM Yeware, D Sarkar, M Fernandes European journal of medicinal chemistry 152, 358-369, 2018 | 9 | 2018 |
| In silico Studies, Synthesis and Antitubercular Activity of Some Novel Quinoline-Azitidinone Derivatives TS Chitre, KD Asgaonkar, AB Vikhe, SM Patil, DR Garud, VM Khedkar, ... Current Computer-Aided Drug Design 17 (1), 134-143, 2021 | 4 | 2021 |
| A high content screening assay for identifying inhibitors against active and dormant state intracellular Mycobacterium tuberculosis A Yeware, S Agrawal, D Sarkar Journal of microbiological methods 164, 105687, 2019 | 4 | 2019 |
| Probes and techniques used in active and the hypoxia-based dormant state of an antitubercular drug screening assay A Yeware, S Akhtar, D Sarkar Medicine in Drug Discovery 13, 100115, 2022 | 2 | 2022 |
| Controlled Degradation of Polycaprolactone Polymers through Ultrasound Stimulation TJ Yeingst, JH Arrizabalaga, FS Rawnaque, LP Stone, A Yeware, ... ACS Applied Materials & Interfaces 15 (29), 34607-34616, 2023 | 1 | 2023 |
| A murine model with JAK2V617F expression in both hematopoietic cells and vascular endothelial cells recapitulates the key features of human myeloproliferative neoplasm H Zhang, A Yeware, S Lee, H Zhan Frontiers in Oncology 11, 753465, 2021 | 1 | 2021 |
| Novel gene similar to nitrite reductase (NO forming) plays potentially important role in the latency of tuberculosis S Agrawal, S Gample, A Yeware, D Sarkar Scientific reports 11 (1), 19813, 2021 | 1 | 2021 |
| DRUG SCREENING PROGRAM FOR DORMANT STATE OF MYCOBACTERIUM TUBERCULOSIS A Yeware Pharmaceutical Resonance 3 (1), 2020 | 1* | 2020 |
| Novel fourth generation-like CARmiR cells release therapeutic miRNA via exosomes and enhance glioblastoma cell killing activity A Yeware, A Helton, Y Dong, C Dong, J Pritchard, S Mineishi, ... Biochemical Engineering Journal 199, 109068, 2023 | | 2023 |
| Development of new dormancy model in the Mycobacterium spp for the novel drug screening program A Yeware Academy of Scientific and Innovative Research (AcSIR), 2022 | | 2022 |
